Galantamini hydrobromidum (Galantamine hydrobromide)

Name:Galantamine hydrobromide (Galantamini hydrobromidum)

Indications for use:
Myasthenia gravis (muscle weakness), myopathy (mouse disease); sensory and motor disorders caused by neuritis (inflammation of the nerve); residual effects after poliomyelitis: psychogenic and spinal impotence; if necessary, as an antidote (antidote) of muscle relaxants (means that relax muscles) during anesthesia, etc.

Pharmacological action:
Active anticholinesterase agent, reversible cholinesterase inhibitor.

Galantamini hydrobromidum (Galantamine hydrobromide) method of administration and doses:
Subcutaneously, 0.251 ml of a 1% solution 12 times every day; children, depending on age – 0.10.7 ml of 0.25% solution; as an antidote injected into a vein (152025 mg).

Galantamini hydrobromidum (Galantamine hydrobromide) contraindications:
Epilepsy, hyperkinesis (involuntary muscle contractions of the limbs), angina pectoris, bradycardia (slow pulse), bronchial asthma.

Galantamini hydrobromidum (Galantamine hydrobromide) side effects:
In case of overdose, salivation, dizziness, bradycardia (slow pulse).

Release form:
Ampoules of 1 ml 0.25%; 0.5% and 1% solution in a pack of 10 pcs.

Nivalin, Galantamine, Galantamine hydrobromide.

Storage conditions:
List A. In a place protected from light.

Galantamine alkaloid hydrobromide isolated from Voronov’s snowdrop tubers (Galantus Woronowi A. Los.).

Before using the medication“Galantamini hydrobromidum (Galantamine hydrobromide)” should be consulted with a doctor.
The instructions are provided solely for familiarization with “Galantamini hydrobromidum (Galantamine hydrobromide) .”

Leave a Comment

Your email address will not be published. Required fields are marked *